Scegli la tua regione

Seleziona la regione che meglio si adatta alla tua posizione o alle tue preferenze.

International

Scegli la lingua del sito

Questa impostazione controlla la lingua dell'interfaccia utente, inclusi i pulsanti, i menu e tutto il testo del sito. Seleziona la tua lingua preferita per la migliore esperienza di navigazione.

Scegli le lingue per gli annunci di lavoro

Seleziona le lingue per gli annunci di lavoro che desideri vedere. Questa impostazione determina quali annunci di lavoro ti verranno mostrati.

Corticalis AS

Oslo, Norvegia

Visita il sito web

Informazioni sul datore di lavoro

Corticalis AS was founded in 2001 by Prof. Jan Eirik Ellingsen and Prof. Staale Petter Lyngstadaas. The two founders still own approximately 75% of the company, the remainder is owned by key persons within the organization. The company is devoted to research and development of bone regenerative technologies and biomaterials. The company is performing early-stage, pre-clinical in vitro and animal studies and all of its inventions are within the field described above. The company’s main assets next to its researchers are its patents and patent applications. Since its inception, the company has successfully developed and licensed out/sold several patent portfolios to major players within the dental implant industry. The Company is focusing all its R & D on its three new technologies, a titanium based ceramic bone graft material (NuBone®), a synthetic peptide family (NuPep™) and a paste for peri-implantitis treatment (NuGel™).